OvaScience, VC Fund Settle Investor Class Action For $15M
OvaScience and its venture capital backer Longwood Fund have agreed to pay $15 million to resolve an investor class action saying the Massachusetts fertility company's alleged misrepresentations about the success of...To view the full article, register now.
Already a subscriber? Click here to view full article